Experimental atherosclerosis in rabbits: Platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin

This publication has 25 references indexed in Scilit:

• The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits
  Prostaglandins, 1977
• : A selective inhibitor of thromboxane synthetase
  Prostaglandins, 1977
• A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets
  Pharmacological Research Communications, 1977
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
  Nature, 1976
• Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances
  Prostaglandins, 1974
• Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2
  Nature New Biology, 1973
• Cholesterol esterifying enzymes of atherosclerotic rabbit intima
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962